Presentation: Pediatric Anaphylaxis at a University Hospital in Cheonan, Korea, 2013~2014. ( World Allergy Congress)

Friday, 16 October 2015

Hall D1 Foyer (Floor 3) (Coex Convention Center)

Jun Seak Gang, MD , Department of Pediatrics, Soonchunhyang University Hospital, Cheonan, South Korea

Joon Soo Park, MD, PhD , Department of Pediatrics, Soonchunhyang University Hospital, Cheonan, South Korea

Young Hwangbo, MD, PhD. , Department of Preventive Medicine, Soonchunhyang University, Cheonan, South Korea

Hyun Jung Lee, MD, PhD. , Department of Emergency Medicine, Soonchunhyang University Hospital, Cheonan, South Korea

Hye Sun Kim, RN , Department of Pediatrics, Soonchunhyang University Hospital, Cheonan, South Korea

Tae Ho Kim, MD , Department of Pediatrics, Soonchunhyang University Hospital, Cheonan, South Korea

Hyun Ho Bang, MD , Department of Pediatrics, Soonchunhyang University Hospital, Cheonan, South Korea

Kyeong Bae Park, MD, PhD. , Department of Pediatrics, Soonchunhyang University Hospital, Cheonan, South Korea

Gyeong Hee Yoo, MD, PhD. , Department of Pediatrics, Soonchunhyang University Hospital, Cheonan, South Korea

Seung Soo Kim, MD, PhD. , Department of Pediatrics, Soonchunhyang University Hospital, Cheonan, South Korea

Young Chang Kim, MD, PhD. , Department of Pediatrics, Soonchunhyang University Hospital, Cheonan, South Korea

Background

Epinephrine is the first treatment for anaphylaxis. To investigate the clinical features of pediatric anaphylaxis, including the rate of using epinephrine and prescribing epinephrine auto-injector.

Methods

We performed a retrospective study in in-patients, out-patients, and emergency department visitors, who were under 15 years old, at Soonchunhyang University Hospital, Cheonan, Korea, from Jan. 2013 through Dec. 2014. A total of 68 patients were diagnosed with anaphylaxis by criteria at the time.

Results

The causes of anaphylaxis were food (77.9%), drug (10.3%) and idiopathic (11.8%). The involved organs were cutaneous (88.2%), respiratory (80.9%), cardiovascular (20.6%), and gastrointestinal tract (14.7%). Patients were treated with systemic steroid (92.6%), anti-histamine (88.2%) and epinephrine (76.5%). 53 (77.9%) patients re-visited our pediatric allergy clinic and epinephrine auto-injectors were prescribed for 25 (36.8%) patients.

Conclusion

Epinephrine was not used in more than 20% and epinephrine auto-injectors were not prescribed for more than 60% of pediatric anaphylaxis patents. Physicians should make an effort to use epinephrine as the initial treatment of anaphylaxis and to prescribe epinephrine auto-injector.

3174 Pediatric Anaphylaxis at a University Hospital in Cheonan, Korea, 2013~2014.